Eleftherios Anastasopoulos1, Anne L Coleman2, M Roy Wilson3, Janet S Sinsheimer4, Fei Yu2, Sokratis Katafigiotis5, Panayiota Founti1, Angeliki Salonikiou1, Theofanis Pappas1, Archimidis Koskosas1, Theodora Katopodi5, Alexandros Lambropoulos5, Fotis Topouzis1. 1. Department of Ophthalmology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece. 2. Center for Eye Epidemiology, Jules Stein Eye Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States. 3. School of Medicine, Wayne State University, Detroit, Michigan, United States. 4. Department of Human Genetics, Department of Biomathematics, David Geffen School of Medicine at UCLA and Department of Biostatistics, UCLA School of Public Health, California, United States. 5. Laboratory of General Biology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Abstract
PURPOSE: To investigate the association of the two single-nucleotide polymorphisms (SNPs) in the lysyl oxidase-like 1 (LOXL1) gene with pseudoexfoliation syndrome (PEX), pseudoexfoliative glaucoma (PEXG), and primary open-angle glaucoma (POAG) in a Greek population-based setting, from the Thessaloniki Eye study. METHODS: A total of 233 subjects with successful DNA extraction, PCR amplification, and genotyping were included in the genetic analysis of G153D and R141L SNPs of LOXL1 gene and classified into four groups: controls (n = 93); subjects with PEX (n = 40); POAG (n = 66); and PEXG (n = 34). Multinomial logistic regression was used to test their association with LOXL1 SNPs with adjustment for covariates. The association of LOXL1 with IOP (in untreated subjects) and with systemic diseases was explored. RESULTS: Both LOXL1 SNPs were present in high frequencies in controls and cases. The G153D was strongly associated with both PEX (odds ratio [OR] = 23.2, P = 0.003 for allele G) and PEXG (OR = 24.75, P = 0.003 for allele G) and was not associated with POAG (P = 0.451). In contrast, the R141L was not associated with PEX (P = 0.81), PEXG (P = 0.063), or POAG (P = 0.113). No association of the G153D with either intraocular pressure (IOP) or systemic diseases was found. CONCLUSIONS: In the Thessaloniki Eye Study, the G153D SNP of LOXL1 gene was strongly associated with both PEX and PEXG, whereas the R141L was not associated. No association of the LOXL1 with IOP or with systemic diseases was found. These findings further support the hypothesis that the LOXL1 gene contributes to onset of PEXG through PEX. Gene variants of LOXL1 do not help to identify those with PEX at increased risk for glaucoma development. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.
PURPOSE: To investigate the association of the two single-nucleotide polymorphisms (SNPs) in the lysyl oxidase-like 1 (LOXL1) gene with pseudoexfoliation syndrome (PEX), pseudoexfoliative glaucoma (PEXG), and primary open-angle glaucoma (POAG) in a Greek population-based setting, from the Thessaloniki Eye study. METHODS: A total of 233 subjects with successful DNA extraction, PCR amplification, and genotyping were included in the genetic analysis of G153D and R141L SNPs of LOXL1 gene and classified into four groups: controls (n = 93); subjects with PEX (n = 40); POAG (n = 66); and PEXG (n = 34). Multinomial logistic regression was used to test their association with LOXL1 SNPs with adjustment for covariates. The association of LOXL1 with IOP (in untreated subjects) and with systemic diseases was explored. RESULTS: Both LOXL1 SNPs were present in high frequencies in controls and cases. The G153D was strongly associated with both PEX (odds ratio [OR] = 23.2, P = 0.003 for allele G) and PEXG (OR = 24.75, P = 0.003 for allele G) and was not associated with POAG (P = 0.451). In contrast, the R141L was not associated with PEX (P = 0.81), PEXG (P = 0.063), or POAG (P = 0.113). No association of the G153D with either intraocular pressure (IOP) or systemic diseases was found. CONCLUSIONS: In the Thessaloniki Eye Study, the G153D SNP of LOXL1 gene was strongly associated with both PEX and PEXG, whereas the R141L was not associated. No association of the LOXL1 with IOP or with systemic diseases was found. These findings further support the hypothesis that the LOXL1 gene contributes to onset of PEXG through PEX. Gene variants of LOXL1 do not help to identify those with PEX at increased risk for glaucoma development. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.
Authors: Haoyu Chen; Li Jia Chen; Mingzhi Zhang; Weifeng Gong; Pancy Oi Sin Tam; Dennis Shun Chiu Lam; Chi Pui Pang Journal: Mol Vis Date: 2010-02-06 Impact factor: 2.367
Authors: R R Allingham; M Loftsdottir; M S Gottfredsdottir; E Thorgeirsson; F Jonasson; T Sverisson; W G Hodge; K F Damji; E Stefánsson Journal: Br J Ophthalmol Date: 2001-06 Impact factor: 4.638
Authors: Subhabrata Chakrabarti; Kollu Nageswara Rao; Inderjeet Kaur; Rajul S Parikh; Anil K Mandal; Garudadri Chandrasekhar; Ravi Thomas Journal: Invest Ophthalmol Vis Sci Date: 2008-01-25 Impact factor: 4.799
Authors: Lydia Álvarez; Montserrat García; Héctor González-Iglesias; Julio Escribano; Pedro P Rodríguez-Calvo; Luis Fernández-Vega; Miguel Coca-Prados Journal: BMC Med Genet Date: 2015-08-31 Impact factor: 2.103
Authors: Marios P Giannakopoulos; Anna G Antonacopoulou; Anastasia E Kottorou; Haralabos P Kalofonos; Sotirios P Gartaganis Journal: Clin Ophthalmol Date: 2016-04-22